Aurélie De Bruycker
- ORCID iD
-
0000-0002-3583-481X
Show
Sort by
-
Microbiome and metabolome dynamics during radiotherapy for prostate cancer
-
Chest wall reconstruction for deep radiation necrosis : case report and overview of surgical options
-
Detection and treatment of oligorecurrent prostate cancer : the next step towards cure
(2022) -
- Journal Article
- A1
- open access
Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer : analysis of STOMP and ORIOLE trials
-
- Journal Article
- A1
- open access
PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : a study protocol for a randomized controlled phase II trial
-
- Journal Article
- A1
- open access
A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer
-
Re: Gaetan Devos, Gert De Meerleer, Steven Joniau. Have we entered the era of imaging before salvage treatment for recurrent prostate cancer? Eur Urol 2019;76:265-7
-
Standard of care versus metastases-directed therapy for PET-detected nodal oligorecurrent prostate cancer following multimodality treatment : a multi-institutional case-control study
-
Nodal oligorecurrent prostate cancer : anatomic pattern of possible treatment failure in relation to elective surgical and radiotherapy treatment templates
-
Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer : not ready for prime time
-
Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial
-
- Journal Article
- A1
- open access
Prospective comparison of F-18 choline PET/CT scan versus axial MRI for detecting bone metastasis in biochemically relapsed prostate cancer patients
-
Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy